According to mouse mammary tumor models, SRC-3 deficiency significantly impaired mammary tumorigenesis without alteration of the expression of E2 and progesterone-responsive genes [77,78], which suggests that SRC-3 also promotes breast malignant tumors through other signaling pathways. The gene discussed is NCOA3; the disease is breast cancer.